AlphaHunt
Healthcare

VRTX Stock Analysis

Vertex Pharmaceuticals Incorporated · current price $459.10 (+1.28% today)

★★★★ Quality 66/ Alpha Score
Solid setup — 3/4 EPS beats, 36% net margin. Momentum, fundamentals and macro indicators are aligned.
LAST EARNINGS Vertex Pharmaceuticals Incorporated (VRTX)

Latest earnings

EPS
$4.52 vs $4.25 est · +0.1% vs estimate BEAT
Revenue
$2.99B · +0.8% YoY
Stock reaction (1M)
+4.0%
Beat streak
3 of last 4 quarters

Key metrics

Alpha Score
66/100
Grade
B
Rev Growth YoY
+7.8%
30-day Momentum
+4.0%
Forward P/E
26.9×
Analyst Target
$548.69
Implied Upside
+19.5%

Latest news on VRTX

Similar stocks in Healthcare

BIIB WST LLY WAT MRNA HOLX

View all Healthcare stocks →

VRTX — frequently asked

What is VRTX's Alpha Score?

Vertex Pharmaceuticals Incorporated (VRTX) currently has a TickerMover Alpha Score of 66/100, rated ★★★★ Quality. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Vertex Pharmaceuticals Incorporated (VRTX) a buy?

TickerMover does not give buy or sell recommendations. VRTX scores 66/100 (★★★★ Quality) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is VRTX's score updated?

VRTX's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for VRTX →
TickerMover is a research tool, not financial advice. Alpha Score is a composite signal — always do your own research before investing.
Last updated automatically every 5 minutes during US market hours.
Questions? support@tickermover.com